Literature DB >> 17163522

Hematological abnormalities during the first week of life among neonates with Down syndrome: data from a multihospital healthcare system.

E Henry1, D Walker, S E Wiedmeier, R D Christensen.   

Abstract

Various hematological abnormalities have been reported among neonates with Down syndrome. Thrombocytosis, thrombocytopenia, polycythemia, neutrophilia, transient myeloproliferative disorder (TMD), and congenital leukemia have all been reported. The two largest case series previously reported involved 63 and 31 cases. To acquire hematological data from a larger case series, we obtained all CBCs done during the first week after birth on all neonates with Down syndrome cared for in an Intermountain Healthcare (IHC) hospital with a date of birth between January 1, 2001 and December 31, 2005. During this period, 145,522 live births were recorded at 18 hospitals. Down syndrome was recognized in 226 (1 in 644). One hundred fifty-eight (70%) of these had one or more CBCs obtained before the seventh day (144 hr). Neonates who did versus did not have a CBC in the first week had a similar gestational age, birth weight, percentage who were LGA and SGA, and length of stay. Neutrophilia was the most common hematological abnormality detected, with 80% of absolute neutrophil counts above the upper limit of normal for age. Six percent (9/158) had blasts identified on the blood film and three, where this was persistent, were referred to the pediatric hematology service for further evaluation. The next most commonly detected abnormality was thrombocytopenia, with 66% of platelet counts <150,000/microl, and with 6% of counts <50,000/microl. The mean platelet volume did not correlate with the platelet count, but tended to run slightly large (9.2 +/- 1.3 fl), with 24% of values above 10 fl. Only one had a platelet transfusion. Polycythemia was the next most common hematological abnormality detected, with 33% of hematocrit values above 65% or hemoglobin concentrations above 22 g/dl. Six had a reduction transfusion. One patient had significant anemia (hematocrit <15%) and received an erythrocyte transfusion. One had neutropenia associated with an infection after bowel surgery. Neutrophilia, thrombocytopenia, and polycythemia were the most common hematological abnormalities observed among neonates with Down syndrome. Anemia, thrombocytosis, and neutropenia were not more common than among neonates who do not have Down syndrome. Hematological abnormalities were so common in this group that it seems reasonable to recommend that one or more CBCs be obtained on all neonates with Down syndrome. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17163522     DOI: 10.1002/ajmg.a.31442

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  20 in total

1.  DOWN'S SYNDROME WITH NEONATAL ALLOIMMUNE THROMBOCYTOPENIA DUE TO HLA-A2 ANTIBODY.

Authors:  Toshihiko Nakamura; Tomoaki Nomura; Takashi Kamohara; Hidehiro Takahashi; Daisuke Hatanaka; Michiko Kusakari; Mari Nakamura; Kinuyo Kawabata; Hitoshi Ohto
Journal:  Fukushima J Med Sci       Date:  2015-12-03

2.  Hematopoietic disorders in Down syndrome.

Authors:  John K Choi
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

3.  Tumorigenesis in Down's syndrome: big lessons from a small chromosome.

Authors:  Dean Nižetić; Jürgen Groet
Journal:  Nat Rev Cancer       Date:  2012-09-21       Impact factor: 60.716

4.  Comparing automated vs manual leukocyte differential counts for quantifying the 'left shift' in the blood of neonates.

Authors:  B C MacQueen; R D Christensen; B A Yoder; E Henry; V L Baer; S T Bennett; H M Yaish
Journal:  J Perinatol       Date:  2016-06-09       Impact factor: 2.521

Review 5.  Hematological disorders and leukemia in children with Down syndrome.

Authors:  Annelyse Bruwier; Christophe F Chantrain
Journal:  Eur J Pediatr       Date:  2011-11-24       Impact factor: 3.183

6.  Perturbation of fetal hematopoiesis in a mouse model of Down syndrome's transient myeloproliferative disorder.

Authors:  Yehudit Birger; Liat Goldberg; Timothy M Chlon; Benjamin Goldenson; Inna Muler; Ginette Schiby; Jasmin Jacob-Hirsch; Gideon Rechavi; John D Crispino; Shai Izraeli
Journal:  Blood       Date:  2013-05-29       Impact factor: 22.113

7.  The calcineurin-NFAT pathway negatively regulates megakaryopoiesis.

Authors:  Alexander Zaslavsky; Stella T Chou; Keri Schadler; Allyson Lieberman; Maxim Pimkin; Yeo Jung Kim; Kwan-Hyuck Baek; William C Aird; Mitchell J Weiss; Sandra Ryeom
Journal:  Blood       Date:  2013-02-27       Impact factor: 22.113

8.  Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells.

Authors:  Stella T Chou; Marta Byrska-Bishop; Joanna M Tober; Yu Yao; Daniel Vandorn; Joanna B Opalinska; Jason A Mills; John Kim Choi; Nancy A Speck; Paul Gadue; Ross C Hardison; Richard L Nemiroff; Deborah L French; Mitchell J Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

9.  Syndromic thrombocytopenia and predisposition to acute myelogenous leukemia caused by constitutional microdeletions on chromosome 21q.

Authors:  Marwan Shinawi; Ayelet Erez; Deborah L Shardy; Brendan Lee; Rizwan Naeem; George Weissenberger; A Craig Chinault; Sau Wai Cheung; Sharon E Plon
Journal:  Blood       Date:  2008-05-16       Impact factor: 22.113

Review 10.  A System to Study Aneuploidy In Vivo.

Authors:  Sarah J Pfau; Angelika Amon
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2016-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.